Placental transfer of quetiapine in relation to P-glycoprotein activity

Journal of Psychopharmacology

Volumn 21, Issue 7, 2007, Pages 751-756

  Rahi, Melissa ^a,b   Heikkinen, Tuija ^b   Härtter, Sebastian ^c   Hakkola, Jukka ^d   Hakala, Kristo ^b   Wallerman, Ola ^e   Wadelius, Mia ^f   Wadelius, Claes ^e   Laine, Kari ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF OULU   (Finland)

^e UPPSALA UNIVERSITY   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ABCB1 polymorphism; P glycoprotein; Placenta; Quetiapine

Indexed keywords

ALANINE; CYSTEINE; ELACRIDAR; GLYCINE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PHENAZONE; QUETIAPINE; THREONINE; VALSPODAR;

AMINO ACID SUBSTITUTION; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; FEMALE; HUMAN; NORMAL HUMAN; PLACENTA PERFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ACRIDINES; ALLELES; ANTIPSYCHOTIC AGENTS; ANTIPYRINE; CYCLOSPORINS; DIBENZOTHIAZEPINES; DRUG INTERACTIONS; EXONS; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; IMMUNOBLOTTING; MATERNAL-FETAL EXCHANGE; P-GLYCOPROTEIN; PERFUSION; PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; TETRAHYDROISOQUINOLINES;

EID: 34548728543     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106074065     Document Type: Article

References (31)

1. American Academy of Pediatrics, Committee on Drugs (2000) Use of psychoactive medications during pregnancy and possible effects on the fetus and newborn. Pediatrics 105: 880 - 887
2. Boulton D.W., DeVane C.L., Liston H.L., Markowitz J.S. (2002) In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sciences 71: 163 - 169
3. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695 - 698
4. Ela A A E, Härtter S., Schmitt U., Hiemke C., Spahn-Langguth H., Langguth P. (2004) Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds - implications for pharmacokinetics of selected substrates. J Pharm Pharmacol 56: 967 - 975
5. Food and Drug Administration (1980) Labelling and prescription drug advertising: content and format for labelling for human prescription drug. Fed Reg 44: 37434-37467
6. Gentile S. (2004) Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 38 (7). 1265 - 1271
7. Green B. (1999) Focus on quetiapine. Curr Med Res Opin. 15 (3). 145 - 151.
8. Grimm S.W., Richtand N.M., Winter H.R., Stams K.R., Reele S.B. (2005) Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol 61 (1). 58 - 69
9. Heikkinen T., Ekblad U., Laine K. (2001) Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta. Psychopharmacology 153: 450 - 454
10. Holcberg G., Sapir O., Tsadkin M., Huleihel M., Lazer S., Katz M., Mazor M., Ben-Zvi Z. (2003) Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 109 (2). 133 - 137
11. Johnstone R.W., Ruefli A.A., Smyth M.J. (2000) Multiple physiological functions for multidrug transporter P-glycoprotein. Trends Biochem Sci 25: 1 - 6
12. Kalabis G.M., Kostak A., Andrews M.H., Petropoulos S., Gibb W., Matthews S.G. (2005) Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod 73: 591 - 597
13. Lankas G.R., Wise L.D., Cartwright M.E., Pippert T., Umbenhauer D.R. (1998) Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 12: 457 - 463
14. McKenna K., Koren G., Tetelbaum M., Wilton L., Shakir S., Diav-Citrin O., Levinson A., Zipursky R.B., Einarson A. (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 66 (4). 444 - 449
15. Mandrioli R., Fanali S., Ferranti A., Raggi M.A. (2002) HPLC analysis of the novel antipsychotic drug quetiapine in human plasma. J Pharm Biomed Anal 30: 969 - 977
16. Marzolini C., Paus E., Buclin T., Kim R.B. (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75 (1). 13 - 33
17. Mathias A.A., Hitti J., Unadkat J.D. (2005) P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289: R963 - R969
18. Meats P. (1997) Quetiapine ('Seroquel'). an effective and well-tolerated atypical antipsychotic. Int J Psych Clin Pract 1: 231 - 239
19. Mölsä M., Heikkinen T., Hakkola J., Hakala K., Wallerman O., Wadelius M., Wadelius C., Laine K. (2005) Functional role of P-glycoprotein in the human blood-placenta barrier. Clin Pharmacol Ther 78 (2). 123 - 131
20. Nakamura Y., Ikeda S., Furukawa T., Sumizawa T., Tani A., Akiyama S., Nagata Y. (1997) Function of P-glycoprotein expressed in placenta and mole. Biochem Biophys Res Commun 235: 849 - 853
21. Pavek P., Fendrich Z., Staud F., Malakova J., Brozmanova H., Laznicek M., Semecky V., Grundmann M., Palicka V. (2001) Influence of P-glycoprotein on the transplacental passage of cyclosporine. J Pharm Sci 90 (10). 1583 - 1592
22. Sachse J., Köller J., Härtter S., Hiemke C. (2006) Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection. J Chromatogr B 830: 342 - 348
23. Schenker S., Yang Y., Mattiuz E., Tatum D., Lee M. (1999) Olanzapine transfer by human placenta. Clin Exp Pharmacol Physiol 26 (9). 691 - 697
24. Schneider H., Panigel M., Dancis J. (1972) Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114: 822 - 828
25. St-Pierre M.V., Serrano M.A., Macias R.I., Dubs U., Hoechli M., Lauper U., Meier P.J., Marin J.J. (2000) Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279: R1495 - R1503
26. Sun M., Kingdom J., Baczyk D., Lye S.J., Matthews S.G., Gibb W. (2005) Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27: 602 - 609
27. Taylor T.M., O'Toole M.S., Ohlsen R.I., Walters J., Pilowsky L.S. (2003) Safety of quetiapine during pregnancy. Am J Psychiatry 160: 588 - 589
28. Tenyi T., Trixler M., Keresztes Z. (2002) Quetiapine and pregnancy. Am J Psychiatry 159: 674
29. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735 - 7738
30. Yaris F., Yaris E., Kadioglu M., Ulku C., Kesim M., Kalyoncu N.I. (2004) Use of polypharmacotherapy in pregnancy: a prospective outcome in a case. Prog Neuropsychopharmacol Biol Psychiatry 28: 603 - 605
31. Young A.M., Allen C.E., Audus K.L. (2003) Efflux transporters of the human placenta. Adv Drug Deliv Rev 55: 125 - 132